<DOC>
	<DOCNO>NCT02663583</DOCNO>
	<brief_summary>The goal laboratory research study learn symptom activity level patient OPSCC receive IMPT TORS .</brief_summary>
	<brief_title>Intensity-Modulated Proton Therapy ( IMPT ) TransOral Robotic Surgery ( TORS ) Treatment Low-Risk Oropharynx Squamous Cell</brief_title>
	<detailed_description>Baseline Visit : If participant agrees take part study , complete follow test procedure baseline visit . This baseline visit take place participant 's treatment IMPT TORS : - Participant complete questionnaire symptom cancer may affect daily life work home , diet , speech . - Participant complete Dysphagia Inventory . This questionnaire difficult swallow . - The study staff measure wide participant open jaw see treatment may cause jaw open limitation . It take 30 minute complete questionnaire . As part participant 's baseline visit , information collect medical record : - Participant 's medical history - The result participant 's physical exam include weight recent weight loss . - Any disease participant may drug currently take . - Participant 's current smoking status smoke history . Activity Bands : The study staff either give participant activity band baseline visit mail activity wristband . Participant ask wear band 24 hour day 1 week lead study visit . The wristband record active participant much sleep . The study staff show participant wear use wristband . Study Visits : Participant complete follow study procedure complete treatment either IMPT TORS , 3 6 month . - The data participant 's wristband collect . - Participant complete questionnaire baseline . - At participant 's 3 month visit , study staff measure wide open jaw see treatment may cause jaw open limitation . IMPT patient : If participant receiving IMPT , complete questionnaire complete baseline visit week receive treatment . Length Study : Participant 's active participation study 6 month study visit . Participant return wristband study staff participation . If participant lose damage wristband study , another one provide cost . This investigational study . Up 44 participant take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Mouth Neoplasms</mesh_term>
	<criteria>1 . Age â‰¥ 18 year 2 . Histologically document , previously untreated OPSCC ( Clinical Stage IIII ; Tx,02 , N01 ) eligible standard care singlemodality treatment either IMPT TORS 3 . Eastern Cooperative Oncology Group ( ECOG ) = 0 , 1 , 2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Oropharynx squamous cell carcinoma</keyword>
	<keyword>OPSCC</keyword>
	<keyword>Actigraph accelerometer</keyword>
	<keyword>MD Anderson Symptom Inventory - Head Neck module</keyword>
	<keyword>MDASI-HN</keyword>
	<keyword>Intensity-Modulated Proton Therapy</keyword>
	<keyword>IMPT</keyword>
	<keyword>TransOral Robotic Surgery</keyword>
	<keyword>TORS</keyword>
	<keyword>Surveys</keyword>
	<keyword>Questionnaires</keyword>
</DOC>